|

The Cedars-Sinai Smidt Heart Institute Takotsubo Registry & Proteomic Study

RECRUITINGSponsored by Cedars-Sinai Medical Center
Actively Recruiting
SponsorCedars-Sinai Medical Center
Started2019-02-01
Est. completion2029-02
Eligibility
Age18 Years+
Locations1 site
View on ClinicalTrials.gov →

NCT03910569

Summary

The Cedars-Sinai SHI Takotsubo Registry and Proteomic Study is an observational registry that will collect retrospective and prospective demographic, clinical, hemodynamic, laboratory and other diagnostic parameters, therapy and outcome data from individuals who meet the inclusion/exclusion criteria of Takotsubo Registry protocol. Subjects will also be invited to provide a blood sample utilizing a Mitra kit sent to their homes. Researchers from the Barbra Streisand Women's Heart Center will analyze Registry data to identify Takotsubo phenotypes, improve diagnostic capabilities, better predict recurrence rates, and develop targeted Takotsubo treatments.

Eligibility

Age: 18 Years+
Inclusion Criteria:

* Have received a diagnosis of Takotsubo from their physician and consent to enroll
* Submit full medical records needed for Takotsubo adjudication

Exclusion Criteria:

* Younger than 18 years
* Unable to provide informed consent
* Unable to provide the necessary documentation needed for screening purposes

Conditions2

Heart DiseaseTakotsubo Cardiomyopathy

Locations1 site

Cedars Sinai Medical Center
Los Angeles, California, 90005
Jenna Maughan

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.